KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 176 filers reported holding KITE PHARMA INC in Q1 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $15,293,000 | -4.9% | 211,460 | +3.2% | 0.05% | -9.6% |
| Q1 2017 | $16,081,000 | +24.8% | 204,885 | -28.7% | 0.05% | +8.3% |
| Q4 2016 | $12,886,000 | -12.5% | 287,370 | +9.0% | 0.05% | -12.7% |
| Q3 2016 | $14,730,000 | +56.5% | 263,695 | +43.6% | 0.06% | +48.6% |
| Q2 2016 | $9,412,000 | +1248.4% | 183,643 | +1077.2% | 0.04% | +1133.3% |
| Q1 2016 | $698,000 | -27.4% | 15,600 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $961,000 | -63.5% | 15,600 | -67.0% | 0.00% | -66.7% |
| Q3 2015 | $2,634,000 | -58.5% | 47,300 | -45.8% | 0.01% | -53.8% |
| Q2 2015 | $6,353,000 | +32.6% | 87,300 | -8.2% | 0.03% | +30.0% |
| Q1 2015 | $4,791,000 | – | 95,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |